Connect with us

Technology

Preclinical Software for Physiology DA and AS Market to Grow by USD 4.38 Billion from 2025-2029, Driven by Bioinformatics Tools in Research, AI-Powered Market Evolution – Technavio

Published

on

NEW YORK, Feb. 12, 2025 /PRNewswire/ — Report on how AI is driving market transformation – The preclinical software for physiology DA and AS market and it is set to grow by USD 4.38 billion from 2025 to 2029. However, the growth momentum will progressing at a CAGR of over 6% during the forecast period, according to Technavio. The preclinical software for physiology da and as market is fragmented, and the vendors are seeking strong partnerships with automotive, industrial, and commercial companies to compete in the market.  ADInstruments Pty Ltd., BIOPAC Systems Inc., Bruker Corp., Columbus Instruments LLC, emka TECHNOLOGIES, ETISENSE SAS, Harvard Bioscience Inc., Instem Plc, Med Associates Inc., Noldus Information Technology BV, Perkin Elmer Inc., Starr Life Sciences Corp., Stoelting Co., Thermo Fisher Scientific Inc., TSE Systems GmbH, UGO BASILE S.R.L., Vanderbilt University Medical Center, Xybion Digital Inc., and Zaber Technologies Inc. Are some of the major market participants -. To know about the vendor offerings – Request a sample report

Preclinical Software For Physiology DA And AS Market 2025-2029: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The preclinical software for physiology da and as market report covers the following areas:

Preclinical Software For Physiology DA And AS Market SizePreclinical Software For Physiology DA And AS Market TrendsPreclinical Software For Physiology DA And AS Market Industry AnalysisPorter’s Five Forces AnalysisCustomer Landscape

The preclinical software for physiology da and as market is fragmented, and the degree of fragmentation will accelerate. The emerging role of bioinformatics tools and software in preclinical research will offer immense growth opportunities. However, the Stringent ethical framework using animals in preclinical research will hamper the market growth

Preclinical Software For Physiology DA And AS Market 2025-2029: Drivers & Challenges

Preclinical software for Data Analysis (DA) and Automated Scoring (AS) in the field of physiology plays a significant role in drug development and discovery. Bioinformatics tools are essential for various reasons, such as utilizing preclinical data for secondary research, managing data during clinical trials, and expanding knowledge on human diseases and overall health. Advanced technologies like proteomics, molecular dynamics simulation, molecular docking, and quantitative structure-activity relationships expedite the drug discovery process. In the preclinical research phase, this software is extensively used for designing study plans with randomization, ensuring unbiased results.

In the preclinical software market for physiology data assessment and animal supervision, ethical considerations are paramount when it comes to animal studies. These studies play a vital role in scientific and biomedical advancements, as well as drug discovery. However, ethical concerns surrounding animal usage are a significant issue. Regulations for animal studies are based on both logistical and technical requirements, as well as ethical principles. Ethical evaluations are necessary for licensing these studies, typically carried out by ethics committees such as the American Association of Psychologists’ (APA) Animal Research and Ethics (CARE) Committee. The APA’s Guidelines for Ethical Conduct in the Care and Use of Animals provide a framework for researchers to adhere to.

To learn more about the global trends impacting the future of market research, download a PDF sample

Segment Overview 

This preclinical software for physiology da and as market report extensively covers market segmentation by  

End-userIndustrial Labs And CROsAcademic Government And Research LabsDeploymentOn-premisesCloudGeographyNorth AmericaEuropeAsiaRest Of World (ROW)

1.1 Industrial labs and CROs-  Preclinical research is a crucial stage in the development of new drugs and medical devices for healthcare and biopharmaceutical companies. Major pharmaceutical and biotechnology firms have established in-house capabilities for conducting preclinical and clinical studies. However, many companies opt to outsource these activities to Contract Research Organizations (CROs) to reduce costs and access a wider range of equipment and laboratory facilities, including preclinical software. CROs offer services such as genetic engineering, safety and efficacy testing in animal models, hit exploration and lead optimization, assay development, target validation, and clinical trials. However, some pharmaceutical and biotechnology companies, particularly those focusing on chronic conditions and disorders, prefer to keep their preclinical research in-house for greater control and precision. The industrial labs and CROs segment is expected to dominate the global preclinical software market for physiology data assessment and animal supervision due to the high demand for outsourcing preclinical research activities.

To learn more, request a FREE sample

Preclinical Software For Physiology DA And AS Market 2025-2029: Key Highlights

CAGR of the market during the forecast period 2025-2029Detailed information on factors that will assist preclinical software for physiology da and as market growth during the next five yearsEstimation of the preclinical software for physiology da and as market size and its contribution to the parent marketPredictions on upcoming trends and changes in consumer behaviorThe growth of the preclinical software for physiology da and as market across North America, Europe, Asia, and Rest of World (ROW)Analysis of the market’s competitive landscape and detailed information on vendorsComprehensive details of factors that will challenge the growth of preclinical software for physiology da and as market vendors

Preclinical Software For Physiology DA And AS Market Scope

Report Coverage

Details

Base year

2024

Historic period

2017-2021

Forecast period

2025-2029

Growth momentum & CAGR

Accelerate at a CAGR of 6%

Market growth 2025-2029

USD 4381.7 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

5.3

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 44%

Key countries

US, UK, Germany, Japan, Canada, France, China, Italy, India, and The Netherlands

Competitive landscape

Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

ADInstruments Pty Ltd., BIOPAC Systems Inc., Bruker Corp., Columbus Instruments LLC, emka TECHNOLOGIES, ETISENSE SAS, Harvard Bioscience Inc., Instem Plc, Med Associates Inc., Noldus Information Technology BV, Perkin Elmer Inc., Starr Life Sciences Corp., Stoelting Co., Thermo Fisher Scientific Inc., TSE Systems GmbH, UGO BASILE S.R.L., Vanderbilt University Medical Center, Xybion Digital Inc., and Zaber Technologies Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

About US
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/preclinical-software-for-physiology-da-and-as-market-to-grow-by-usd-4-38-billion-from-2025-2029–driven-by-bioinformatics-tools-in-research-ai-powered-market-evolution—technavio-302374243.html

SOURCE Technavio

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

JAMS Launches AI for Enterprise Job Scheduling: JAX and JAMS MCP, on the Model You Choose

Published

on

By

A new AI agent and an open-standard connector let IT teams query, diagnose, and manage automation in plain language, on the model they choose, with operational data staying inside their own network

LONDON, July 24, 2026 /PRNewswire/ — JAMS Software, an orchestration solution for scheduled and event-driven automation, today announced the general availability of two AI capabilities for enterprise job scheduling: JAX, an AI agent built into the JAMS Web Client, and JAMS MCP, a connector built on the open Model Context Protocol standard that brings JAMS into external AI coding tools. Both capabilities ship at no additional cost as part of JAMS Web.

Automation environments grow faster than the teams that run them. Jobs multiply across SQL Server, Azure Data Factory, Airflow, SAP, JDE, and Banner, and when one fails, finding the root cause often means searching several consoles at once, frequently outside business hours. At the same time, IT leaders carry pressure to adopt AI while staying accountable for where operational data goes. JAX and JAMS MCP close both gaps together.

Full details on how JAX and JAMS MCP work, including the control model behind every action, are available at jamsscheduler.com/product/ai.

JAX is an AI agent that runs inside the JAMS Web Client. It finds jobs, troubleshoots failures, and answers how-to questions in plain language, with each response grounded in the JAMS user guide and checked against a built-in glossary. JAX acts only when a user asks it to. Reads flow freely, and every write action pauses for the user’s explicit approval before it runs. JAX does not learn between sessions, and conversations are not retained on the server.

JAMS MCP is a connector, built on the open Model Context Protocol standard, that brings JAMS into the AI tools engineering teams already use, including Cursor, VS Code with Copilot, Claude Code, Claude Desktop, and Codex. Users query jobs, investigate failures, and manage runs in plain language without leaving their tool.

Both capabilities run inside the customer’s own network and act as the signed-in user, with that user’s exact JAMS permissions. There is no elevated AI account: whatever a user cannot do in the JAMS interface, JAX and JAMS MCP cannot do on that user’s behalf. Every JAX and MCP operation is recorded in its own dedicated log, and changes made through the JAMS API land in the JAMS audit trail like any other change. Customers choose their own AI model, whether a commercial provider such as OpenAI or Anthropic or a model running entirely on their own hardware, and JAMS never trains on customer data. In the current release, neither feature edits or deletes a job, folder, schedule, or agent definition. For teams that must keep operational data within a defined boundary, JAX runs on a local model entirely inside the customer’s own network, so nothing leaves at all.

“Adopting AI usually means giving something up, most often visibility into where your data goes,” said Pete Hegland, Chief Executive Officer of JAMS Software. “We built JAX and JAMS MCP so that trade does not have to happen. Every action runs as the signed-in user, every change waits for approval, and the model itself can run entirely inside your own network.”

“IT teams across the United Kingdom and EMEA tell us the same thing: they want the benefit of AI without losing sight of where their data goes,” said Greg McLaughlin, Account Executive for EMEA at JAMS Software. “JAX and JAMS MCP let them keep operational data inside their own network and still get answers in plain language. That combination is what makes this practical for the teams I work with.”

JAX and JAMS MCP are available now to all JAMS Web customers across the United Kingdom and EMEA, with no separate licence, SKU, or additional cost. AI-assisted creation of new jobs and workflows from a plain-language description is on the roadmap for a future release, gated by the same approvals and permissions as every other action.

Learn how JAX and JAMS MCP work at https://jamsscheduler.com/product/ai.

Fast facts

JAX is an AI agent built into the JAMS Web Client for job scheduling and workflow automation.JAMS MCP is a connector built on the open Model Context Protocol standard, for Cursor, VS Code with Copilot, Claude Code, Claude Desktop, and Codex.Both act as the signed-in user, with that user’s exact JAMS permissions, and there is no elevated AI account.Customers choose the AI model, including a local model that runs entirely inside their own network.JAMS never trains on customer data.Both are available now at no additional cost as part of JAMS Web.

About JAMS Software

Founded in 1987, JAMS Software is an orchestration solution that helps IT teams centralize, automate, and manage scheduled and event-driven jobs across complex, hybrid environments. Over 850 customers rely on JAMS to run their automated workloads. JAMS Software, LLC is headquartered at 108 Patriot Drive, Suite A, Middletown, DE 19709.

Media Contact
Bobby Schmidt, Vice President of Marketing
press@jamssoftware.com
800.261.4267

 

 

Logo – https://mma.prnewswire.com/media/3007577/JAMS_logo.jpg
Photo – https://mma.prnewswire.com/media/3007578/jams_jax_ai_agent_job_scheduling_1.jpg
Photo – https://mma.prnewswire.com/media/3007579/jams_jax_mcp_ai_control_model.jpg
Photo – https://mma.prnewswire.com/media/3007580/jams_mcp_ai_connector_claude_cursor.jpg

View original content:https://www.prnewswire.co.uk/news-releases/jams-launches-ai-for-enterprise-job-scheduling-jax-and-jams-mcp-on-the-model-you-choose-302833908.html

Continue Reading

Technology

Video: CNPC offers green chemical answer

Published

on

By

BEIJING, July 24, 2026 /PRNewswire/ — A news report from chinadaily.com.cn:

Located on the edge of the Taklamakan Desert in Northwest China’s Xinjiang Uygur autonomous region, the Tarim 1.2 MTA Phase II Ethylene Project and its supporting green and low-carbon demonstration facility of PetroChina Dushanzi Petrochemical Company, a subsidiary of China National Petroleum Corporation, are offering a new example of China’s low-carbon industrial transformation.

Watch the video to discover how CNPC is exploring a cleaner and more circular future for the industry.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/video-cnpc-offers-green-chemical-answer-302834036.html

SOURCE chinadaily.com.cn

Continue Reading

Technology

Shanghai Electric showcases embodied intelligence robot matrix and AI-native smart factory solutions at WAIC 2026

Published

on

By

Featuring humanoid robots with 41 degrees of freedom, pipe‑inspection robots with ±1mm positioning accuracy, and 51 industrial‑grade AI agents

SHANGHAI, July 24, 2026 /PRNewswire/ — Operations in high-end equipment manufacturing often involve confined spaces, complex objects, and fine manipulation tasks that demand sustained and stable precision. At the recent 2026 World Artificial Intelligence Conference and High-Level Meeting on Global AI Governance (WAIC 2026), Shanghai Electric (SEHK: 02727, SSE: 601727) showcased its comprehensive portfolio of embodied intelligence solutions tailored to a range of industrial scenarios.

Themed “AI for All: Smart Squad, Shining Without Limits,” Shanghai Electric highlighted its capabilities across embodied AI robots, robot core components, and AI-native smart factory solutions, demonstrating end-to-end capabilities spanning complete robot systems, critical parts, industrial software, and smart factory architecture.

“The true value of embodied intelligence lies in understanding real industrial tasks: combining the strength, precision, and stability of machines with human experience and judgment to drive a genuine paradigm of ‘machine-assisted, human-machine collaboration,'” said Wang Chunlei, deputy general manager of the Robotics Business Unit at Shanghai Electric Automation Group.

Shanghai Electric’s robotics portfolio covers five key industrial scenarios: connector insertion, electrical operations, flexible sorting, intelligent assembly, and pipe processing. Highlights include:

“SUYUAN” bipedal humanoid robot: With 41 degrees of freedom for enhanced mobility, it is equipped with a multimodal visual sensing system on the head and torso, along with a dual-battery hot-swap system. It is well-suited for inspection, material handling, and assembly tasks.”TUOYUAN” industrial wheeled humanoid robot: Powered by an embodied intelligence foundation model and force-position hybrid control, it is capable of multi-spec connector insertion, material sorting, and loading/unloading of automotive sheet metal parts.”Mermaid” bionic wheeled humanoid robot: Capable of autonomously identifying buttons, knobs, and air switches, it generates real-time operation paths.Autonomous pipe inner-wall chamfering robot: Designed for confined spaces, it can position and process thousands of hole edges with accuracy within 1 millimeter while transmitting data in real time.

Shanghai Electric also showcased its portfolio of core components ranging from power-output to end effectors. Among them, the planetary roller screw offers more than three times the load capacity of traditional ball screws, while the DexHand dexterous hand is designed to meet diverse gripping and manipulation requirements.

Shanghai Electric launched 51 AI models and agents under its “StarCloud Intelligent Manufacturing” series across three domains: R&D and design, production and manufacturing, and operations and maintenance—covering critical equipment processes such as process optimization and wind power facility maintenance.

These industrial agents are embedded in robotic decision-making systems and the operational logic of AI-native smart factories, transforming industrial expertise into digitized, reusable capabilities. They support production-line scheduling, quality inspection, and predictive maintenance, driving the evolution of manufacturing systems from experience-driven to data-driven operations.

Shanghai Electric also released the “AI-Native Smart Factory Technology White Paper,” proposing an active evolution architecture that enables real‑time, closed‑loop optimization of production data, giving the factory self‑perception, self‑decision, and self‑execution capabilities. Built on First Principles, the AI‑native smart factory vertically integrates process flows, industrial software, agents, and smart equipment to dismantle traditional hierarchies while horizontally bridging data silos. The architecture features three core layers: the AI factory brain as the “control center,” industrial agents and embodied robots as the “execution network,” and the physical twin as the “digital mirror.”

Leveraging its deep industrial expertise and comprehensive solution capabilities, Shanghai Electric will continue to drive the implementation of AI in industrial settings, tackle technical challenges facing embodied intelligence in complex scenarios, accelerate the large‑scale deployment of AI‑native smart factories, and deliver replicable solutions across diverse manufacturing environments.

SOURCE Shanghai Electric

Continue Reading

Trending